These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 2845847)

  • 1. Dendritic cells and antigen presentation in the regulation of cytotoxic T lymphocyte responses against viruses and transplantation antigens.
    Melief CJ; Boog CJ; Vasmel WL; Boes J; Voordouw AC; Kast WM
    Ann N Y Acad Sci; 1988; 532():280-91. PubMed ID: 2845847
    [No Abstract]   [Full Text] [Related]  

  • 2. Dendritic cells: open for presentation business.
    Saveanu L; van Endert P
    Nat Immunol; 2005 Jan; 6(1):7-8. PubMed ID: 15611772
    [No Abstract]   [Full Text] [Related]  

  • 3. Pathways of viral antigen processing and presentation to CTL: defined by the mode of virus entry?
    Long EO; Jacobson S
    Immunol Today; 1989 Feb; 10(2):45-8. PubMed ID: 2665772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Class I antigen presentation.
    Jelachich ML; Biddison WE
    Year Immunol; 1989; 4():41-58. PubMed ID: 2522701
    [No Abstract]   [Full Text] [Related]  

  • 5. Defective presentation of endogenous antigen by a cell line expressing class I molecules.
    Hosken NA; Bevan MJ
    Science; 1990 Apr; 248(4953):367-70. PubMed ID: 2326647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunology. Accessory to murder.
    Schumacher TN
    Nature; 1999 Mar; 398(6722):26-7. PubMed ID: 10078525
    [No Abstract]   [Full Text] [Related]  

  • 7. Failure or success in the restoration of virus-specific cytotoxic T lymphocyte response defects by dendritic cells.
    Kast WM; Boog CJ; Roep BO; Voordouw AC; Melief CJ
    J Immunol; 1988 May; 140(9):3186-93. PubMed ID: 2834454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. On cross-priming of MHC class I-specific CTL: rule or exception?
    Zinkernagel RM
    Eur J Immunol; 2002 Sep; 32(9):2385-92. PubMed ID: 12207322
    [No Abstract]   [Full Text] [Related]  

  • 9. Regulation of the cytotoxic T lymphocyte response against Sendai virus analyzed with H-2 mutants.
    de Waal LP; Kast WM; Melvold RW; Melief CJ
    J Immunol; 1983 Mar; 130(3):1090-6. PubMed ID: 6185570
    [No Abstract]   [Full Text] [Related]  

  • 10. Brefeldin A specifically inhibits presentation of protein antigens to cytotoxic T lymphocytes.
    Yewdell JW; Bennink JR
    Science; 1989 Jun; 244(4908):1072-5. PubMed ID: 2471266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinguishable pathways of viral antigen presentation to T lymphocytes.
    Morrison LA; Braciale VL; Braciale TJ
    Immunol Res; 1986; 5(4):294-304. PubMed ID: 3298467
    [No Abstract]   [Full Text] [Related]  

  • 12. Primary virus-induced lymphomas evade T cell immunity by failure to express viral antigens.
    Vasmel WL; Sijts EJ; Leupers CJ; Matthews EA; Melief CJ
    J Exp Med; 1989 Apr; 169(4):1233-54. PubMed ID: 2538550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Virus-specific cytotoxic T cells in multiple sclerosis.
    McFarland HF; Goodman A; Jacobson S
    Ann N Y Acad Sci; 1988; 532():273-9. PubMed ID: 3263072
    [No Abstract]   [Full Text] [Related]  

  • 14. Antigen presentation requires transport of MHC class I molecules from the endoplasmic reticulum.
    Cox JH; Yewdell JW; Eisenlohr LC; Johnson PR; Bennink JR
    Science; 1990 Feb; 247(4943):715-8. PubMed ID: 2137259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumour-specific CTL response requiring interactions of four different cell types and recognition of MHC class I and class II restricted tumour antigens.
    Schirrmacher V; Schild HJ; Gückel B; von Hoegen P
    Immunol Cell Biol; 1993 Aug; 71 ( Pt 4)():311-26. PubMed ID: 7901150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytotoxic T-cell immunity to virus-infected non-haematopoietic cells requires presentation of exogenous antigen.
    Sigal LJ; Crotty S; Andino R; Rock KL
    Nature; 1999 Mar; 398(6722):77-80. PubMed ID: 10078533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antigen presentation to cytotoxic T lymphocytes in vivo.
    Bevan MJ
    J Exp Med; 1995 Sep; 182(3):639-41. PubMed ID: 7650475
    [No Abstract]   [Full Text] [Related]  

  • 18. Antigen presentation by Langerhans cells in vivo: donor-derived Ia+ Langerhans cells are required for induction of delayed-type hypersensitivity but not for cytotoxic T lymphocyte responses to alloantigens.
    Peeler JS; Niederkorn JY
    J Immunol; 1986 Jun; 136(12):4362-71. PubMed ID: 3519767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cross-presentation of glycoprotein 96-associated antigens on major histocompatibility complex class I molecules requires receptor-mediated endocytosis.
    Singh-Jasuja H; Toes RE; Spee P; Münz C; Hilf N; Schoenberger SP; Ricciardi-Castagnoli P; Neefjes J; Rammensee HG; Arnold-Schild D; Schild H
    J Exp Med; 2000 Jun; 191(11):1965-74. PubMed ID: 10839811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Presentation of MUC1 tumor antigen by class I MHC and CTL function correlate with the glycosylation state of the protein taken Up by dendritic cells.
    Hiltbold EM; Alter MD; Ciborowski P; Finn OJ
    Cell Immunol; 1999 Jun; 194(2):143-9. PubMed ID: 10383817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.